Chemoselective Heck arylation of acrolein diethyl acetal catalyzed by an oxime-derived palladacycle
作者:Carmen Nájera、Luis Botella
DOI:10.1016/j.tet.2005.06.059
日期:2005.10
at 90 °C in aqueous DMA using (dicylohexyl)methylamine as base, whereas for bromoarenes the reaction has to be performed at 120 °C using tetra-n-butylammonium bromide (TBAB) as additive. Alternatively, this process can be performed under microwave irradiation. These couplings take place in good yields and with lower catalyst loading than with palladium(II) acetate as well as in shorter reaction times
甲二聚4-羟基苯乙酮肟衍生钯化合物已被用作一种非常有效的预催化剂用于通过反应条件的适当选择丙烯醛缩二乙醇,得到任一肉桂醛衍生物或3- arylpropanoate酯的化学选择性芳基化。肉桂醛衍生物的合成可以通过丙烯醛缩二乙醇与碘,在溴-或氯代芳烃的Heck反应进行Ñ,Ñ用k二甲基乙酰胺(DMA)2 CO 3作为在120℃下和四-碱Ñ-醋酸丁丁基铵(TBAA)和氯化钾作为添加剂,然后进行酸处理。对于3-芳基丙酸酯,相应的丙烯醛二乙缩醛与碘芳烃的芳基化反应可以在90°C的DMA水溶液中使用(二(己基己基)甲胺)碱进行,而溴芳烃的反应则必须在120°C的条件下使用四芳基进行。 -溴化正丁基铵(TBAB)作为添加剂。或者,该过程可以在微波辐射下进行。与乙酸钯(II)相比,这些偶联以高收率和较低的催化剂负载量发生,并且反应时间较短且丙烯醛二乙基缩醛过量的发生率较低。
3-Arylpropanoate Esters throughthe Palladium-Catalyzed Reaction of Aryl Halides with Acrolein DiethylAcetal
The reaction of aryl halides with acrolein diethyl acetal in the presence of Pd(OAC) 2 , n-Bu 3 N, and n-Bu 4 NCl in DMF at 90°C affords ethyl 3-arylpropanoates. A variety of functional groups are tolerated in the aryl halides, including ether, aldehyde, ketone, ester, nitrile, and nitro groups. ortho-Substituents do not hamper the reaction. 3-Arylpropanoate esters were isolated in good to excellent
Methods of modulating protein tyrosine kinase function with substituted indolinone compounds
申请人:SUGEN, INC.
公开号:US20040067531A1
公开(公告)日:2004-04-08
The invention relates to certain indolinone compounds, their method of synthesis, and a combinatorial library consisting of the indolinone compounds. The invention also relates to methods of modulating the function of protein tyrosine kinases using indolinone compounds and methods of treating diseases by modulating the function of protein tyrosine kinases and related signal transduction pathways.
Process for producing optically active 3-hydroxypropionic ester derivative
申请人:Taoka Naoaki
公开号:US20060166342A1
公开(公告)日:2006-07-27
The present invention is to provide a process for simply producing an optically active 3-hydroxypropionic ester derivative useful as a medicament intermediate from an inexpensive material. More specifically, the present invention is directed to a process for producing an optically active 3-hydroxypropionic ester derivative comprising reacting an acetic ester derivative available at low cost with abase and a formic ester, thereby converting the acetic ester derivative into a 2-formylacetic ester derivative, and thereafter, stereospecifically reducing the formyl group of the derivative by use of an enzymatic source capable of stereoselectively reducing the formyl group of the derivative.
3-methylidenyl-2-indolinone modulators of protein kinase
申请人:Sugen, Inc.
公开号:US20040024010A1
公开(公告)日:2004-02-05
The present invention relates to novel 3-methylidenyl-2-indolinone compounds and physiologically acceptable salts and prodrugs thereof which modulate the activity of protein kinases and therefore are expected to be useful in the prevention and treatment of protein kinase related cellular disorders such as cancer.